4
Views
0
CrossRef citations to date
0
Altmetric
Review

Female functional bladder outlet obstruction: treatment with α-blockers

&
Pages 241-247 | Published online: 10 Jan 2014

References

  • Abrams P, Cardozo L, Fall M et al. Standardisation Sub-committee of the International Continence Society. The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Neurourol. Urodyn.21(2), 167–178 (2002).
  • Haylen BT, de Ridder D, Freeman RM et al. International Urogynecological Association; International Continence Society. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Neurourol. Urodyn.29(1), 4–20 (2010).
  • Chassagne S, Bernier PA, Haab F, Roehrborn CG, Reisch JS, Zimmern PE. Proposed cutoff values to define bladder outlet obstruction in women. Urology51(3), 408–411 (1998).
  • Lemack GE, Zimmern PE. Pressure flow analysis may aid in identifying women with outflow obstruction. J. Urol.163(6), 1823–1828 (2000).
  • Defreitas GA, Zimmern PE, Lemack GE, Shariat SF. Refining diagnosis of anatomic female bladder outlet obstruction: comparison of pressure–flow study parameters in clinically obstructed women with those of normal controls. Urology64(4), 675–679 (2004).
  • Nitti VW, Tu LM, Gitlin J. Diagnosing bladder outlet obstruction in women. J. Urol.161(5), 1535–1540 (1999).
  • Blaivas JG, Groutz A. Bladder outlet obstruction nomogram for women with lower urinary tract symptomatology. Neurourol. Urodyn.19(5), 553–564 (2000).
  • Cormier L, Ferchaud J, Galas JM, Guillemin F, Mangin P. Diagnosis of female bladder outlet obstruction and relevance of the parameter area under the curve of detrusor pressure during voiding: preliminary results. J. Urol.167(5), 2083–2087 (2002).
  • Gravina GL, Costa AM, Ronchi P, Galatioto GP, Luana G, Vicentini C. Bladder outlet obstruction index and maximal flow rate during urodynamic study as powerful predictors for the detection of urodynamic obstruction in women. Neurourol. Urodyn.26(2), 247–253 (2007).
  • Akikwala TV, Fleischman N, Nitti VW. Comparison of diagnostic criteria for female bladder outlet obstruction. J. Urol.176(5), 2093–2097 (2006).
  • Haylen BT, Ashby D, Sutherst JR, Frazer MI, West CR. Maximum and average urine flow rates in normal male and female populations – the Liverpool nomograms. Br. J. Urol.64(1), 30–38 (1989).
  • Coyne KS, Sexton CC, Thompson CL et al. The prevalence of lower urinary tract symptoms (LUTS) in the USA, the UK and Sweden: results from the Epidemiology of LUTS (EpiLUTS) study. BJU Int.104(3), 352–360 (2009).
  • Stanton SL, Ozsoy C, Hilton P. Voiding difficulties in the female: prevalence, clinical and urodynamic review. Obstet. Gynecol.61(2), 144–147 (1983).
  • Massey JA, Abrams PH. Obstructed voiding in the female. Br. J. Urol.61(1), 36–39 (1988).
  • Groutz A, Blaivas JG, Chaikin DC. Bladder outlet obstruction in women: definition and characteristics. Neurourol. Urodyn.19(3), 213–220 (2000).
  • Massey JA, Abrams PH. Obstructed voiding in the female. Br. J. Urol.61(1), 36–39 (1988).
  • Carlson KV, Fiske J, Nitti VW. Value of routine evaluation of the voiding phase when performing urodynamic testing in women with lower urinary tract symptoms. J. Urol.164(5), 1614–1618 (2000).
  • Costantini E, Mearini E, Pajoncini C, Biscotto S, Bini V, Porena M. Uroflowmetry in female voiding disturbances. Neurourol. Urodyn.22(6), 569–573 (2003).
  • Haylen BT, Krishnan S, Schulz S et al. Has the true prevalence of voiding difficulty in urogynecology patients been underestimated? Int. Urogynecol. J. Pelvic Floor Dysfunct.18(1), 53–56 (2007).
  • Diokno AC, Hollander JB, Bennett CJ. Bladder neck obstruction in women: a real entity. J. Urol.132(2), 294–298 (1984).
  • Padmanabhan P, Nitti VW. Primary bladder neck obstruction in men, women, and children. Curr. Urol. Rep.8(5), 379–384 (2007).
  • Swinn MJ, Fowler CJ. Isolated urinary retention in young women, or Fowler’s syndrome. Clin. Auton. Res.11(5), 309–311 (2001).
  • DasGupta R, Fowler CJ. The management of female voiding dysfunction: Fowler’s syndrome – a contemporary update. Curr. Opin. Urol.13(4), 293–299 (2003).
  • Sinha S. Dysfunctional voiding: a review of the terminology, presentation, evaluation and management in children and adults. Indian J. Urol.27(4), 437–447 (2011).
  • Kilicarslan H, Ayan S, Vuruskan H, Gokce G, Gultekin EY. Treatment of detrusor sphincter dyssynergia with baclofen and doxazosin. Int. Urol. Nephrol.38(3–4), 537–541 (2006).
  • Mahfouz W, Karsenty G, Corcos J. Injection of botulinum toxin type A in the urethral sphincter to treat lower urinary tract dysfunction: review of indications, techniques and results: 2011 update. Can. J. Urol.18(4), 5787–5795 (2011).
  • Yee CH, Ho LY, Hung HH, Chan WH.The effect of urethral calibration on female primary bladder outlet obstruction. Int. Urogynecol. J.23(2), 217–221 (2012).
  • Axelrod SL, Blaivas JG. Bladder neck obstruction in women. J. Urol.137(3), 497–499 (1987).
  • Grønbaek K, Struckmann JR, Frimodt-Møller C. The treatment of female bladder neck dysfunction. Scand. J. Urol. Nephrol.26(2), 113–118 (1992).
  • Kumar A, Mandhani A, Gogoi S, Srivastava A. Management of functional bladder neck obstruction in women: use of alpha-blockers and pediatric resectoscope for bladder neck incision. J. Urol.162(6), 2061–2065 (1999).
  • Fu Q, Xu YM. Transurethral incision of the bladder neck using KTP in the treatment of bladder neck obstruction in women. Urol. Int.82(1), 61–64 (2009).
  • Yablonsky F, Riffaud JP, Lacolle JY, Dausse JP. Alpha 1- and alpha 2-adrenoceptors in the smooth muscle of male and female rabbit urethra. Eur. J. Pharmacol.121(1), 1–8 (1986).
  • Morita T, Latifpour J, O’Hollaren B, Wheeler MA, Weiss RM. Sex differences in function and distribution of alpha 1- and alpha 2-adrenoceptors in rabbit urethra. Am. J. Physiol.252(6 Pt 2), 1124–1128 (1987).
  • Taki N, Taniguchi T, Okada K, Moriyama N, Muramatsu I. Evidence for predominant mediation of alpha1-adrenoceptor in the tonus of entire urethra of women. J. Urol.162(5), 1829–1832 (1999).
  • Nasu K, Moriyama N, Fukasawa R et al. Quantification and distribution of alpha1-adrenoceptor subtype mRNAs in human proximal urethra. Br. J. Pharmacol.123(7), 1289–1293 (1998).
  • Sigala S, Peroni A, Mirabella G et al. Alpha1-adrenoceptor subtypes in human urinary bladder: sex and regional comparison. Life Sci.76(4), 417–422 (2004).
  • Thind P, Lose G, Colstrup H, Andersson KE. The effect of alpha-adrenoceptor stimulation and blockade on the static urethral sphincter function in healthy females. Scand. J. Urol. Nephrol.26(3), 219–225 (1992).
  • Reitz A, Haferkamp A, Kyburz T, Knapp PA, Wefer B, Schurch B. The effect of tamsulosin on the resting tone and the contractile behaviour of the female urethra: a functional urodynamic study in healthy women. Eur. Urol.46(2), 235–240 (2004).
  • Bouchelouche K, Andersen L, Alvarez S, Nordling J, Bouchelouche P. Increased contractile response to phenylephrine in detrusor of patients with bladder outlet obstruction: effect of the alpha1A and alpha1D-adrenergic receptor antagonist tamsulosin. J. Urol.173(2), 657–666 (2005).
  • Gerstenberg TC, Lykkegaard Nielsen M, Lindenberg J. Spastic striated external sphincter syndrome imitating recurrent urinary tract infection in females. Effect of long-term alpha-adrenergic blockade with phenoxybenzamine. Eur. Urol.9(2), 87–92 (1983).
  • Pischedda A, Pirozzi Farina F, Madonia M, Cimino S, Morgia G. Use of alpha1-blockers in female functional bladder neck obstruction. Urol. Int.74(3), 256–261 (2005).
  • Kessler TM, Studer UE, Burkhard FC. The effect of terazosin on functional bladder outlet obstruction in women: a pilot study. J. Urol.176(4 Pt 1), 1487–1492 (2006).
  • Chang SJ, Chiang IN, Yu HJ. The effectiveness of tamsulosin in treating women with voiding difficulty. Int. J. Urol.15(11), 981–985 (2008).
  • Athanasopoulos A, Gyftopoulos K, Giannitsas K, Perimenis P. Effect of alfuzosin on female primary bladder neck obstruction. Int. Urogynecol. J. Pelvic Floor Dysfunct.20(2), 217–222 (2009).
  • Costantini E, Lazzeri M, Bini V et al. Open-label, longitudinal study of tamsulosin for functional bladder outlet obstruction in women. Urol. Int.83(3), 311–315 (2009).
  • Lee KS, Han DH, Lee YS et al. Efficacy and safety of tamsulosin for the treatment of non-neurogenic voiding dysfunction in females: a 8-week prospective study. J. Korean Med. Sci.25(1), 117–122 (2010).
  • Koh JS, Kim SJ, Kim HS, Kim JC.Comparison of alpha-blocker, extracorporeal magnetic stimulation alone and in combination in the management of female bladder outlet obstruction. Int. Urogynecol. J.22(7), 849–854 (2011).
  • Low BY, Liong ML, Yuen KH et al. Terazosin therapy for patients with female lower urinary tract symptoms: a randomized, double-blind, placebo controlled trial. J. Urol.179(4), 1461–1469 (2008).
  • Pummangura N, Kochakarn W. Efficacy of tamsulosin in the treatment of lower urinary tract symptoms (LUTS) in women. Asian J. Surg.30(2), 131–137 (2007).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.